Faculty

Institution

Unit

Venue

Xiaowei Dong

Associate Professor Pharmaceutical Sciences ; Member Institute for Healthy Aging

University of North Texas Health Science Center

Affiliations

College of Biomedical and Translational Sciences

Pharmaceutical Sciences

College of Pharmacy

Pharmaceutical Sciences

University of North Texas Health Science Center

Texas Center for Health Disparities

Texas College of Osteopathic Medicine

UNT System College of Pharmacy

UNT System College of Pharmacy ; Pharmaceutical Sciences ; Institute for Healthy Aging

Xiaowei Dong is currently serving as a College Of Biomedical And Translational Sciences Associate Professor Pharmaceutical Sciences ; Member Institute for Healthy Aging at University of North Texas Health Science Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Xiaowei Dong

University of North Texas Health Science Center

Associate Professor Pharmaceutical Sciences ; Member Institute for Healthy Aging

You can click a keyword to filter the displayed items

drug delivery biomedical engineering controlled release pharmacology nanoparticle research nano-drug delivery nanoparticles nanomedicine pharmaceutics pharmaceutical nanotechnology therapeutic nanomaterials drug delivery systems biological engineering situ self-assembly nanoparticles medicinal research applied pharmacology biomaterials drug discovery pharmaceutical sciences tumor targeting lipid preparation tumor biology pharmacotherapy pharmacological research pharmaceutical technology medicine oncology cancer research in vitro toxicology biofabrication anti-cancer agents protein nanoparticles cerebral blood flow clinical lipidology clinical chemistry cellular therapy drug analysis cancer treatment polymer-drug conjugate nanotoxicology neural tissue engineering novel hdl-mimicking nanoparticles brain tumor research cancer care continuous delivery neuromodulation (medicine) brain imaging cancer biology cancer management nanobiotechnology biomedical technologies pharmaceutical biotechnology immunological biomarkers clinical immunology extracellular microvesicles in vivo systems cerebral vascular regulation cerebral organoids industrial pharmacy drug development pharmaceutical research pharmaceutical chemistry brain drug delivery current strategies nanomedicinal strategies current progress multidrug-resistant tumors depleting atp multidrug resistance paclitaxel-loaded lipid-based nanoparticles sequential simplex optimization extracellular vesicles t‐cell immunotolerance metformin bio-distribution relevant paradigm vivo evaluation pediatrics leukemia multiple drug resistance lipids pharmaceutical preparations nanotechnology metabolism nerve growth factor alcohol dehydrogenase blood-brain barrier self assembly biological availability particle size fatty alcohols adenosine triphosphate

Notable Scholarly Works

Notable Federal Grants

Collaborators

Influences of Formulations and Administration Routes on Docetaxel Tissue Distribution in Mice. Scientific Reports (2026)

in vitro toxicologypharmacologydocetaxel tissue distributionbiomedical engineeringadministration routesdrug metabolismdrug deliveryapplied pharmacologyclinical researchpharmacological studiesclinical pharmacologytissue (biology)pharmacological researchpharmaceutics

Binary Lipid System-Based Granules With Undissolved Drug Crystals Enhance Oral Bioavailability by Preventing Degradation and Improving Permeability. International Journal of Pharmaceutics (2025)

controlled releasebiomedical engineeringlipid preparationlipidsoral bioavailabilitybiomolecular engineeringbiopolymersundissolved drug crystalsdrug delivery systemsdrug deliverybiological engineeringpharmaceutics

Enhancing Oral Absorption of an Ester Prodrug by Coating Drug Crystals With Binary Lipid Systems and Evaluating the Influence of Compositions. Pharmaceutics (2025)

pharmaceutical technologybinary lipid systemspharmacologycontrolled releaseexcipientslipid preparationlipidspharmaceutical sciencesbiopolymersester prodrugdrug crystalsdrug delivery systemsdrug deliverybiological engineeringpharmaceutics

Investigation of Hydrolysis of Olmesartan Medoxomil in Different Ph Buffers by Simultaneously Measuring Olmesartan Medoxomil and Olmesartan. PLoS ONE (2025)

pharmacologybiochemical engineeringchemical engineeringdrug analysisanalytical chemistrydifferent ph buffersolmesartan medoxomilanalytical toxicology

Exploring Novel Type of Lipid-Bases Drug Delivery Systems That Contain One Lipid and One Water-Soluble Surfactant Only. International Journal of Pharmaceutics (2024)

pharmaceutical technologypharmacologycontrolled releasenovel typelipidswater-soluble surfactantapplied pharmacologydrug discoverybiomoleculesdrug delivery systemsdrug deliverybiological engineeringdelivery systemspharmaceutics

Maximum Tolerated Dose and Toxicity Evaluation of Orally Administered Docetaxel Granule in Mice. Toxicology Reports (2024)

Xiaowei DongJinmin Zhang

drug safetydocetaxel granulepharmacologydrug allergytoxinsapplied pharmacologytoxicity evaluationtoxicologyoral medicineclinical toxicologytoxicology testingexperimental toxicologydrug delivery

The Development of Lipid-Based Sorafenib Granules to Enhance the Oral Absorption of Sorafenib. Pharmaceutics (2023)

pharmacologycontrolled releasebiomedical engineeringlipid sciencelipid preparationlipidstherapeutic targetsbioactive compoundsoral absorptionmedicinal researchlipid-based sorafenib granulesdrug deliverypharmaceutics

Current Status of in Vitro Models of the Blood-Brain Barrier. Current Drug Delivery (2022)

in vitro toxicologycerebral vascular regulationbiomedical engineeringvascular biologycerebral organoidsin vivo systemscerebral blood flowneurophysiologycurrent statusneuroscienceblood vessels

Design and Evaluation of Two-Step Biorelevant Dissolution Methods for Docetaxel Oral Formulations. AAPS PharmSciTech (2022)

pharmaceutical technologypharmacologycontrolled releasebiomedical engineeringpharmaceutical scienceschromatographybioequivalencedrug deliverydocetaxel oral formulationspharmaceutics

Development of in Situ Self-Assembly Nanoparticles to Encapsulate Lopinavir and Ritonavir for Long-Acting Subcutaneous Injection. Pharmaceutics (2021)

encapsulate lopinavirnanomedicinepharmacologybiomedical engineeringcontrolled releasepharmaceutical nanotechnologylong-acting subcutaneous injectionnanoparticle researchsitu self-assembly nanoparticlesnanoparticlesnano-drug deliverytherapeutic nanomaterialsdrug delivery systemsdrug deliverypharmaceutics

1
2
3
4
10 / page

Xiaowei Dong

Associate Professor Pharmaceutical Sciences ; Member Institute for Healthy Aging

University of North Texas Health Science Center

Affiliations

College of Biomedical and Translational Sciences

Pharmaceutical Sciences

College of Pharmacy

Pharmaceutical Sciences

University of North Texas Health Science Center

Texas Center for Health Disparities

Texas College of Osteopathic Medicine

UNT System College of Pharmacy

UNT System College of Pharmacy ; Pharmaceutical Sciences ; Institute for Healthy Aging

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Xiaowei Dong

University of North Texas Health Science Center

Associate Professor Pharmaceutical Sciences ; Member Institute for Healthy Aging

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Influences of Formulations and Administration Routes on Docetaxel Tissue Distribution in Mice. Scientific Reports (2026)

Binary Lipid System-Based Granules With Undissolved Drug Crystals Enhance Oral Bioavailability by Preventing Degradation and Improving Permeability. International Journal of Pharmaceutics (2025)

Enhancing Oral Absorption of an Ester Prodrug by Coating Drug Crystals With Binary Lipid Systems and Evaluating the Influence of Compositions. Pharmaceutics (2025)

Investigation of Hydrolysis of Olmesartan Medoxomil in Different Ph Buffers by Simultaneously Measuring Olmesartan Medoxomil and Olmesartan. PLoS ONE (2025)

pharmacologybiochemical engineeringchemical engineeringdrug analysisanalytical chemistrydifferent ph buffersolmesartan medoxomilanalytical toxicology

Exploring Novel Type of Lipid-Bases Drug Delivery Systems That Contain One Lipid and One Water-Soluble Surfactant Only. International Journal of Pharmaceutics (2024)

Maximum Tolerated Dose and Toxicity Evaluation of Orally Administered Docetaxel Granule in Mice. Toxicology Reports (2024)

Xiaowei DongJinmin Zhang

drug safetydocetaxel granulepharmacologydrug allergytoxinsapplied pharmacologytoxicity evaluationtoxicologyoral medicineclinical toxicologytoxicology testingexperimental toxicologydrug delivery

The Development of Lipid-Based Sorafenib Granules to Enhance the Oral Absorption of Sorafenib. Pharmaceutics (2023)

Current Status of in Vitro Models of the Blood-Brain Barrier. Current Drug Delivery (2022)

in vitro toxicologycerebral vascular regulationbiomedical engineeringvascular biologycerebral organoidsin vivo systemscerebral blood flowneurophysiologycurrent statusneuroscienceblood vessels

Design and Evaluation of Two-Step Biorelevant Dissolution Methods for Docetaxel Oral Formulations. AAPS PharmSciTech (2022)

pharmaceutical technologypharmacologycontrolled releasebiomedical engineeringpharmaceutical scienceschromatographybioequivalencedrug deliverydocetaxel oral formulationspharmaceutics

Development of in Situ Self-Assembly Nanoparticles to Encapsulate Lopinavir and Ritonavir for Long-Acting Subcutaneous Injection. Pharmaceutics (2021)

1
2
3
4
10 / page